Concepedia
Statistics
Publications
11
Citations
807
H-Index
10
Active since
2016
Affiliations
AstraZeneca (United Kingdom)(Current)
Commissariat à l'Énergie Atomique et aux Énergies Alternatives
CEA Paris-Saclay - Etablissement de Fontenay-aux-roses
Centre National de la Recherche Scientifique
Inserm
Michel E. Vandenberghe is an author at AstraZeneca (United Kingdom) specializing in medicine, neuroscience, and oncology.
Publications per year
2016–2025
Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer’s Disease
Juliette Le Douce, Marianne Maugard, Julien Veran et al. · Cell Metabolism · 2020 · 323 citations · Full text
Life Sciences, Neurobiology, Neuroscience +16
Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer
Michel E. Vandenberghe, Marietta Scott, Paul W. Scorer et al. · Scientific Reports · 2017 · 211 citations · Full text
Medicine, Oncology, Pathology +17
Usability of deep learning and H&E images predict disease outcome-emerging tool to optimize clinical trials
Talha Qaiser, Ching-Yi Lee, Michel E. Vandenberghe et al. · npj Precision Oncology · 2022 · 54 citations · Full text
Prevalence of HER2 low in breast cancer subtypes using the VENTANA anti-HER2/neu (4B5) assay.
Marietta Scott, Michel E. Vandenberghe, Paul Scorer et al. · Journal of Clinical Oncology · 2021 · 53 citations
Medicine, Oncology, Breast Oncology +14
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease
Florent Letronne, Geoffroy Laumet, Anne‐Marie Ayral et al. · EBioMedicine · 2016 · 52 citations · Full text
Life Sciences, Neurology, Neuroscience +14
1–5 of 11